Mumbai-headquartered Bharat Serums and Vaccines Limited (BSV) hosted the groundbreaking ceremony of its new manufacturing plant at Genome Valley in Hyderabad, Telengana. The company is owned by Advent, an American private equity fund. Spread across 10 acres, the $22 million manufacturing facility will increase the company's capacity to produce injectables...
Advent to Acquire Controlling Stake in Indian Biopharma Maker
Boston, MA headquartered global private equity investor Advent International will acquire a majority stake in Mumbai India-based Bharat Serums and Vaccines Limited. The acquisition is expected to close by the end of 2019. Bharat Serums is a biopharmaceuticals company focussed on women’s healthcare, assisted reproductive treatment, and critical care and...